e-learning
resources
Stockholm 2002
Monday 16.09.2002
COPD - Drug therapy 2
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of nebulizer treatment with peptide-containing formulation on bronchial passage in COPD patients
A. V. Molodtsova, T. E. Gembitskaya, M. A. Zaytseva, L. A. Kozhemyakin (St-Petersburg, Russia)
Source:
Annual Congress 2002 - COPD - Drug therapy 2
Session:
COPD - Drug therapy 2
Session type:
Thematic Poster Session
Number:
1601
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. V. Molodtsova, T. E. Gembitskaya, M. A. Zaytseva, L. A. Kozhemyakin (St-Petersburg, Russia). Effects of nebulizer treatment with peptide-containing formulation on bronchial passage in COPD patients. Eur Respir J 2002; 20: Suppl. 38, 1601
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 424s
Year: 2001
Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001
Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Influence of pulmonary function on spacer use for HFA-salbutamol inhalation in asthmatic patients
Source: Eur Respir J 2005; 26: Suppl. 49, 126s
Year: 2005
Evaluation of the acute bronchodilator effect of beclomethasone/formoterol fixed combination on central and peripheral airway dimensions in asthmatic patients
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
Influence of natural lung surfactant inhalations on clinical symptoms and pulmonary function parameters in patients with bronchial asthma
Source: International Congress 2018 – Does asthma phenotyping improve treatment?
Year: 2018
Effect of ELTGOL on removal of lung secretion in patients with COPD
Source: Annual Congress 2007 - Critical care and airways clearance
Year: 2007
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005
Efficacy of the device in targeting tiotropium to the small airways in COPD
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007
Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Effects of inhaled salbutamol on autonomic control of heart rate in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 58s
Year: 2002
Effects of procaterol or salmeterol added to maintenance tiotropium therapy on small airway functions in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010
Changes in airway and tissue mechanics in ventilated COPD patients after nebulized bronchodilator agent
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007
Effect of aclidinium/formoterol fixed-dose combinations on respiratory symptoms in COPD patients
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept